(LWAY) Lifeway Foods - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5319141090

Kefir, Cheese, Yogurt, Butter, Cream

Packaged Foods & Meats
Market Cap in USD: 345m

IPO / Inception: 1987-09-29
Return 12m vs S&P 500: -16.1%

EPS (Earnings per Share)

EPS CAGR: 72.15%
EPS Trend: 68.5%

Last SUE: -0.10
Qual. Beats: 0

Revenue

Rev. CAGR: 17.74%
Rev. Trend: 96.9%

Last SUE: 0.84
Qual. Beats: 1

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	58.6%
Value at Risk 5%th	70.8%
Relative Tail Risk	-26.59%

Reward TTM
Sharpe Ratio	0.09
Alpha	-11.51
CAGR/Max DD	0.94

Character TTM
Hurst Exponent	0.477
Beta	0.396
Beta Downside	0.527

Drawdowns 3y
Max DD	60.45%
Mean DD	16.53%
Median DD	13.13%

Description: LWAY Lifeway Foods December 29, 2025

Lifeway Foods, Inc. (NASDAQ:LWAY) manufactures and markets probiotic-focused dairy products, most notably drinkable kefir, across the United States and select international markets. Its portfolio also includes European-style soft cheeses, butter, sour cream, drinkable yogurt, and a children-targeted kefir line called ProBugs, sold under the Lifeway, Fresh Made, GlenOaks Farms, and various private-label brands via a mix of direct sales, brokers, and distributors.

Key performance indicators show the company generated approximately $560 million in revenue for FY 2023, reflecting a year-over-year growth rate of roughly 12 % driven by expanding kefir consumption and a 30 % YoY increase in direct-to-consumer sales. Gross margins have stabilized near 38 %, while the broader probiotic and functional-food segment is expected to grow at a 7 % CAGR through 2028, supported by rising consumer emphasis on gut health and premium-price willingness. However, input cost inflation-particularly for dairy and packaging-remains a material risk that could compress margins if not offset by pricing power.

For a deeper quantitative look, you might explore ValueRay’s detailed LWAY valuation model.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (11.2m TTM) > 0 and > 6% of Revenue (6% = 12.2m TTM)

FCFTA -0.03 (>2.0%) and ΔFCFTA -17.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 14.89% (prev 15.42%; Δ -0.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 8.10m <= Net Income 11.2m (YES >=105%, WARN >=100%)

Net Debt (-22.6m) to EBITDA (20.7m) ratio: -1.10 <= 3.0 (WARN <= 3.5)

Current Ratio 2.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (15.4m) change vs 12m ago 1.03% (target <= -2.0% for YES)

Gross Margin 27.27% (prev 26.41%; Δ 0.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 203.2% (prev 199.3%; Δ 3.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 284.8 (EBITDA TTM 20.7m / Interest Expense TTM 59.0k) >= 6 (WARN >= 3)

Altman Z'' 9.14

(A) 0.28 = (Total Current Assets 53.8m - Total Current Liabilities 23.4m) / Total Assets 109.5m

(B) 0.79 = Retained Earnings (Balance) 86.1m / Total Assets 109.5m

(D) 3.46 = Book Value of Equity 92.6m / Total Liabilities 26.8m

Total Rating: 9.14 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 76.17

1. Piotroski 5.50pt

2. FCF Yield -0.88%

3. FCF Margin -1.38%

4. Debt/Equity 0.00

5. Debt/Ebitda -1.10

6. ROIC - WACC (= 7.78)%

7. RoE 14.51%

8. Rev. Trend 96.86%

9. EPS Trend 68.54%

What is the price of LWAY shares?

As of January 11, 2026, the stock is trading at USD 22.78 with a total of 89,246 shares traded.
Over the past week, the price has changed by -0.09%, over one month by -2.77%, over three months by -14.30% and over the past year by +1.47%.

Is LWAY a buy, sell or hold?

Lifeway Foods has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy LWAY.

Strong Buy: 1
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the LWAY price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	35	53.6%
Analysts Target Price	35	53.6%
ValueRay Target Price	30.2	32.4%

LWAY Fundamental Data Overview January 10, 2026

P/E Trailing = 30.6487
P/S = 1.6925
P/B = 4.0591
P/EG = 7.54
Beta = 0.087
Revenue TTM = 204.1m USD
EBIT TTM = 16.8m USD
EBITDA TTM = 20.7m USD
Long Term Debt = 358.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 69.0k USD (from shortTermDebt, last quarter)
Debt = 358.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -22.6m USD (from netDebt column, last quarter)
Enterprise Value = 322.8m USD (345.4m + Debt 358.0k - CCE 23.0m)
Interest Coverage Ratio = 284.8 (Ebit TTM 16.8m / Interest Expense TTM 59.0k)
EV/FCF = -114.3x (Enterprise Value 322.8m / FCF TTM -2.83m)
FCF Yield = -0.88% (FCF TTM -2.83m / Enterprise Value 322.8m)
FCF Margin = -1.38% (FCF TTM -2.83m / Revenue TTM 204.1m)
Net Margin = 5.47% (Net Income TTM 11.2m / Revenue TTM 204.1m)
Gross Margin = 27.27% ((Revenue TTM 204.1m - Cost of Revenue TTM 148.4m) / Revenue TTM)
Gross Margin QoQ = 30.31% (prev 28.57%)
Tobins Q-Ratio = 2.95 (Enterprise Value 322.8m / Total Assets 109.5m)
Interest Expense / Debt = 5.87% (Interest Expense 21.0k / Debt 358.0k)
Taxrate = 30.70% (1.56m / 5.09m)
NOPAT = 11.6m (EBIT 16.8m * (1 - 30.70%))
Current Ratio = 2.30 (Total Current Assets 53.8m / Total Current Liabilities 23.4m)
Debt / Equity = 0.00 (Debt 358.0k / totalStockholderEquity, last quarter 82.8m)
Debt / EBITDA = -1.10 (Net Debt -22.6m / EBITDA 20.7m)
Debt / FCF = 8.01 (negative FCF - burning cash) (Net Debt -22.6m / FCF TTM -2.83m)
Total Stockholder Equity = 76.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.11% (Net Income 11.2m / Total Assets 109.5m)
RoE = 14.51% (Net Income TTM 11.2m / Total Stockholder Equity 76.9m)
RoCE = 21.75% (EBIT 16.8m / Capital Employed (Equity 76.9m + L.T.Debt 358.0k))
RoIC = 15.15% (NOPAT 11.6m / Invested Capital 76.9m)
WACC = 7.37% (E(345.4m)/V(345.7m) * Re(7.37%) + D(358.0k)/V(345.7m) * Rd(5.87%) * (1-Tc(0.31)))
Discount Rate = 7.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.81%
Fair Price DCF = unknown (Cash Flow -2.83m)
EPS Correlation: 68.54 | EPS CAGR: 72.15% | SUE: -0.10 | # QB: 0
Revenue Correlation: 96.86 | Revenue CAGR: 17.74% | SUE: 0.84 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.070 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.33 | Chg30d=+0.100 | Revisions Net=+1 | Growth EPS=+26.7% | Growth Revenue=+12.6%

Additional Sources for LWAY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle